# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T17:02:50.795845
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 19873 in / 4656 out
**Response SHA256:** 237049b5b2d39d92

---

## Summary and main verdict

The paper studies France’s staggered *reversals* (80→90 km/h) on two-lane departmental roads after the 2019 LOM, using BAAC accident microdata (2015–2024). The headline is a **sign flip**: (i) cross-département staggered DiD (Callaway–Sant’Anna) suggests **fewer** injury accidents in reversing départements; (ii) a within-département **triple-difference (DDD)** using autoroutes as an internal control suggests **more** injury accidents on treated roads post-reversal.

The topic is important and the “sign reversal” insight is potentially publishable in a top journal **if** the DDD design is made fully credible and inference is tightened. As written, the DDD is suggestive but not yet publication-ready: the identifying assumption is not convincingly defended, exposure/mobility confounding remains (especially road-type substitution), and the staggered timing/heterogeneity issues are not handled as carefully for DDD as for the baseline DiD.

---

# 1. Identification and empirical design (critical)

### 1.1 Baseline staggered DiD (cross-département)
- The paper correctly recognizes the dangers of TWFE under staggered adoption and implements Callaway–Sant’Anna (CS) (Section “Staggered Difference-in-Differences”). That is a strength.
- However, the baseline causal claim (“restoring 90 km/h reduced accidents”) is *not* ultimately believed by the paper itself; it is used as a diagnostic for compositional confounding (urbanization/COVID). That is fine, but it means the baseline DiD is not a credible causal design for the policy parameter.

**Key gap:** the paper’s argument that “clean pre-trends” do not guarantee identification in the presence of a large shock (COVID) is plausible (and important), but you should be more explicit about *what* assumption fails: it is not merely “compositional differences”; it is **differential post-2020 dynamics correlated with treatment**. Currently this is described qualitatively; it needs sharper evidence (see revision requests).

### 1.2 Triple-difference (DDD) as preferred design
The DDD is the core identification strategy (Section “Triple-Difference Design” and Results “Triple-Difference: The Causal Effect”). The idea—use autoroutes as within-département controls—is intuitive, but several assumptions need to be made explicit and stress-tested.

**The required identifying assumption is not just “department-wide shocks net out.”** DDD requires:
1. **No differential shocks that change the *relative* evolution of departmental-road accidents vs autoroute accidents in treated départements at treatment time**, except through the speed-limit change; i.e., parallel trends in the **road-type gap** between treated and never-treated départements.
2. **No road-type-specific exposure shifts induced by treatment** (or at least that such shifts are part of the estimand you want), e.g., traffic reallocation from autoroutes to departmental roads after the reversal.

The paper acknowledges road-type substitution as a limitation (Discussion “Road-type substitution”), but this is potentially **first-order**: if the reversal makes departmental roads more attractive relative to autoroutes, then DDD will attribute a substitution-driven increase in departmental-road accidents to “speed-limit reversal” even if per-VKT risk did not change. That is not necessarily “bias” if your estimand is the *policy package effect* on counts, but then the paper should be explicit that the parameter is a **reduced-form equilibrium effect on accident counts**, not a pure “speed → risk” mechanism.

**More serious concern:** autoroutes are not a neutral control road type.
- Autoroute traffic is disproportionately long-distance and potentially more sensitive to national shocks, fuel prices, holidays, and freight conditions than local departmental roads.
- COVID altered trip purpose composition and long-distance travel much more than local travel in some periods. Even within a département, the “departmental vs autoroute” mix could change differently in rural vs urban départements. That is exactly the kind of differential gap trend that violates DDD.

### 1.3 Treatment definition and partial coverage
Treatment is coded at the département-quarter level (“Post”), but the policy is **segment-specific** and intensity varies widely (median 9% network; Section “Treatment Intensity Variation” and Table 4). This creates two issues:

1. **Misclassification/attenuation**: a binary Post treats a département that changed 2% of roads the same as one that changed 100%. That’s an ITT, but then the magnitudes and interpretation should be consistently ITT and not drift into “effect of restoring 90 km/h” in general.
2. **Selection into which segments change**: départements may choose safer segments for reversion. That selection could mechanically generate *smaller* adverse effects (or even improvements) on the treated network, depending on which roads are re-signed. Without segment-level treatment, the DDD estimates conflate “speed limit increase” with “which roads were selected for 90.”

The intensity interaction helps, but because intensity is measured “approximately” and cross-source (Data “Treatment Panel”), measurement error could be substantial and non-classical (e.g., better-measured in highly engaged/rural councils).

### 1.4 Timing coherence and legal reversals
The legal complication discussion is thoughtful. Still, the rule “use most recent installation date” for annulment/reinstallations (Background “Legal Complications”) risks **post-treatment redefinitions** (treatment status depends on post-treatment legal events). Even if few départements, this should be handled with a transparent alternative coding scheme and a pre-registered style rule (“first installation date”, “signage in effect share-weighted”, etc.) and show robustness.

---

# 2. Inference and statistical validity (critical)

### 2.1 Standard errors and clustering
- The paper reports clustered SEs at the département level, and for DDD also mentions two-way clustering by département and quarter (Robustness “Two-Way Clustering”). This is directionally correct.
- With 97 départements, asymptotic cluster-robust inference is plausible, but for CS-DiD the effective number of clusters per cohort-time cell can be small. It would strengthen credibility to use **wild cluster bootstrap** (or CS’s multiplier bootstrap) for key estimates.

### 2.2 Count outcomes and functional form
The outcomes are counts with many zeros (Data “Panel Construction”). A linear model with FE can be fine for ATT interpretation, but you should demonstrate robustness to:
- Poisson (PPML) with high-dimensional FE (department×road-type FE and quarter FE in DDD), clustered SEs; and/or
- negative binomial (less standard with many FE).

At minimum: show that the sign/magnitude of DDD is similar in **PPML**, because heteroskedasticity plus many zeros can materially affect precision and sometimes point estimates in linear FE.

### 2.3 Staggered adoption + DDD: you likely still have a “forbidden comparisons” problem
A major issue: the paper is careful about staggered adoption in the cross-département DiD (CS), but the **DDD is estimated with a TWFE-style regression with Post\_{dt}** (Equation (3)). With staggered timing, δ₂ is still a weighted average of comparisons across cohorts. If treatment effects evolve dynamically (your DDD event study suggests they do), the static DDD coefficient can be difficult to interpret and can, in principle, inherit negative-weight pathologies.

**Concrete fix:** Collapse the DDD into a single outcome per département-quarter, the *gap*:
\[
Gap_{dt}=Y_{d,\text{dept rd},t}-Y_{d,\text{autoroute},t}
\]
and then estimate **CS-DiD / Sun–Abraham on Gap\_{dt}** using the same cohort definitions. That produces an interpretable, heterogeneity-robust estimator for the DDD estimand.

Right now, the paper’s key causal estimate (+3.05) is not produced by a heterogeneity-robust staggered estimator, despite the paper’s own motivation and framing about staggered DiD methodology.

### 2.4 Internal consistency / numerical checks
There are a few internal coherence flags that need reconciliation:
- The text states the main TWFE accident effect is insignificant (true), but the CS accident ATT in Table 2 is **highly significant** (-5.007, SE 1.102). Later you write that the placebo + main estimates are insignificant and suggest low power (Results “The Placebo Test…”). That characterization does not match Table 2 for the CS estimate.
- The fatality mean used in the power discussion (≈1.2 fatalities per département-quarter) differs from Table 1 (“Mean Killed” 0.897 for treated). This does not invalidate the underpower argument, but you should correct and recompute the MDE with the actual baseline mean/variance used.

---

# 3. Robustness and alternative explanations

### 3.1 Placebos are useful but not decisive
The autoroute placebo as an *outcome* in the cross-département DiD is not a strong test of the DDD assumption. The DDD assumption is about the **evolution of the road-type gap**; you need placebo tests tailored to that.

Recommended placebo designs:
1. **Pre-period placebo adoption dates**: assign each treated département a fake adoption date in 2017–2018 and re-estimate DDD event studies on the gap. Should be flat.
2. **Alternative within-département control road types**: use *routes nationales* (where limits differ and may not follow the same policy) and/or “urban departmental roads” as controls and see whether the sign persists. You already have an “urban departmental road placebo” as an outcome in cross-département DiD; instead, incorporate it into a *DDD-type* framework (dept roads outside agg vs urban dept roads inside agg, if exposure patterns are closer than autoroutes).
3. **Non-eligible roads within département**: if data allow, compare departmental roads outside agg (eligible) to departmental roads inside agg (ineligible). This is not perfect but arguably closer in policing/reporting/traffic mix than autoroutes.

### 3.2 Exposure and mobility confounding remains central
You repeatedly note missing traffic volume data (Discussion “Limitations”). For a road-safety paper in a top journal, the absence of exposure (VKT) is a serious limitation, particularly because:
- COVID created huge changes in VKT.
- The policy plausibly changes route choice (autoroute vs departmental road), which is exactly your control dimension.

You need at least one of:
- direct traffic counts (even partial network) aggregated to département-quarter-roadtype;
- a proxy exposure measure (fuel sales, mobile-phone mobility, Google mobility interacted with rurality) interacted with road type; or
- a design that is robust to exposure changes (segment-level within-dept comparisons where the control segments are more substitutable).

Without this, the paper should be more cautious: the DDD estimate is clearly a policy effect on *counts*, but the mechanism (“speed increases crash frequency”) is not separately identified.

### 3.3 Heterogeneity / intensity
The intensity result is promising but underreported: the paper states DDD intensity is +5.95 (SE 1.65, p<0.001), but this is not shown in the main tables (Table 3 includes “Intensity (share)” but appears to be a *non-DDD* version and is insignificant). For credibility, you need:
- the exact DDD-intensity specification equation;
- a table row with the DDD-intensity coefficient, SE, sample, and clustering;
- a plot showing dose-response (binned shares) and an event study interacted with intensity (or at least early vs late, high vs low share).

### 3.4 Mechanisms vs reduced form
The paper generally labels DDD as ITT (good), but some discussion implies a structural “speed→risk” channel. Given substitution and selection of segments, mechanism claims must be **dialed back** unless you bring in speed measurements (ONISR counters) or exposure.

---

# 4. Contribution and literature positioning

### 4.1 What is the contribution?
The strongest contribution is not “first application of CS to speed limits” (interesting but incremental). The strong contribution is:
- A warning that **modern staggered DiD methods do not solve selection/differential shock confounding**, and a demonstration using within-unit road-type controls.

That said, to land in a top general-interest journal, you need to show that the DDD design is itself airtight and that the substantive findings are policy-relevant beyond a methods cautionary tale.

### 4.2 Missing / advisable citations
Consider adding:
- **Roth, Sant’Anna, Bilinski, Poe (2023, QJE)** on pretrend testing and sensitivity in DiD/event studies—relevant to your “pretrends can mislead” message.
- **Miller, Johnson, Wherry (2020/2021)**-style discussions of pandemic confounding in policy evaluation (you cite Goodman-Bacon/COVID; expanding here helps).
- For staggered DiD practice: **Borusyak, Jaravel, Spiess (2021, AER P&P / working paper)** “revisiting event study designs” (imputation estimator), relevant as an alternative estimator you can apply to the gap outcome.
- On speed limits and safety beyond the classic US repeal studies: add at least one modern quasi-experimental speed-limit paper in Europe if available (even transportation journals), to benchmark magnitudes.

---

# 5. Results interpretation and claim calibration

### 5.1 Interpreting the sign flip
The sign flip is compelling, but the paper currently treats the DDD as “the causal effect” without fully acknowledging that:
- it is causal under a stronger, road-type-specific parallel-trends assumption;
- it may include equilibrium route substitution effects; and
- it is still subject to staggered-adoption aggregation concerns if estimated as a static TWFE interaction.

### 5.2 Magnitudes and policy extrapolation
The back-of-envelope national accident increase (~610/year) is fine as an illustration, but:
- it implicitly assumes the +3.05 applies uniformly across treated départements regardless of share restored; yet you also argue median share is 9%. The implied per-% effect calculation (3.05/9) is not a causal scaling unless intensity is correctly modeled and share is exogenous/accurate.
- Your welfare discussion puts time savings potentially dominating accident costs, but the uncertainty is huge and the fatality effect is underpowered. This is okay if clearly labeled speculative; right now it risks reading like a semi-formal CBA without the needed ingredients.

---

# 6. Actionable revision requests (prioritized)

## (1) Must-fix before acceptance

1. **Re-estimate the core DDD estimand with a heterogeneity-robust staggered estimator**
   - **Why:** Your main methodological framing is staggered DiD pitfalls; the DDD is currently estimated in a way that may reintroduce aggregation/weighting issues under dynamic effects.
   - **Fix:** Construct \(Gap_{dt}=Y_{dept}-Y_{autoroute}\) and estimate CS-DiD (and/or Sun–Abraham / imputation estimator) on Gap with the same cohorts. Report aggregated ATT and an event study.

2. **Sharpen and validate the DDD identifying assumption**
   - **Why:** Autoroutes may not be a credible within-département counterfactual; COVID and travel composition can differentially affect autoroutes vs local roads.
   - **Fix:** Provide targeted evidence:
     - pre-period event-study on Gap (you have some version; make it central and show joint tests of leads);
     - placebo adoption in pre-period;
     - alternative control road types (urban departmental roads; possibly routes nationales) in a DDD/gap framework.

3. **Address exposure/traffic volume confounding more directly**
   - **Why:** Without VKT, the DDD can be driven by road-type substitution or differential volume changes, undermining interpretation.
   - **Fix (minimum viable):**
     - incorporate any available traffic count datasets (even partial) or ONISR/administrative counters;
     - or show robustness controlling for mobility proxies interacted with road type and département (e.g., Google mobility × rurality × road type).
   - If no exposure can be obtained, you must **reframe** the estimand as “effect on accident counts on this road class” and explicitly separate it from per-VKT risk claims.

4. **Report the DDD intensity specification transparently**
   - **Why:** Dose-response is key to credibility, but currently it is asserted without clear reporting (and Table 3’s “Intensity (share)” appears to be a different, non-DDD model).
   - **Fix:** Add the exact equation, and a table row with the DDD×share coefficient, SE, clustering, and interpretation (per 10pp share). Consider binscatter of effects by share.

5. **Inference upgrades for key estimates**
   - **Why:** Cluster-robust SEs may be fragile for CS and event studies; DDD claims hinge on p<0.001.
   - **Fix:** Add wild cluster bootstrap (department clusters) for (i) CS ATT, (ii) DDD ATT-on-gap, and (iii) intensity DDD.

## (2) High-value improvements

6. **Functional-form robustness for counts**
   - **Why:** Many zeros and heteroskedasticity.
   - **Fix:** PPML with high-dimensional FE for the stacked DDD; compare marginal effects to baseline.

7. **Treatment coding sensitivity**
   - **Why:** Annulments/reinstallations and partial rollouts may affect timing.
   - **Fix:** Alternate timing rules (“first installation”, “legal decree date”, exclude ambiguous cases) and show stability.

8. **Clarify which units belong in “never-treated”**
   - **Why:** Some départements (Paris and close suburbs) have “negligible eligible network,” making them strange controls for outcomes defined on departmental roads outside agglomeration.
   - **Fix:** Either exclude such units from the main sample, or show robustness excluding high-urban units and/or weighting by eligible road km.

## (3) Optional polish

9. **Calibrate claims about “confound magnitude”**
   - **Why:** The “8.06 accidents per quarter confound” is presented as a decomposition but is not a formal estimand.
   - **Fix:** Present it as descriptive, or provide a formal Oaxaca-style decomposition if you want to emphasize it.

10. **Tighten the power discussion with consistent baseline moments**
   - **Why:** The fatality mean/variance should match the data used.
   - **Fix:** Recompute MDE using treated-road fatality mean and appropriate clustering.

---

# 7. Overall assessment

### Key strengths
- Important policy question with rich administrative microdata and a timely caution about COVID-era evaluation.
- Correct awareness of staggered DiD pitfalls; uses CS and Sun–Abraham for the baseline.
- The idea of leveraging within-département road-type variation is promising and could be a strong design if validated.

### Critical weaknesses
- The preferred DDD estimate is not yet supported by a fully defensible identification argument (autoroutes may not be a valid control; exposure shifts likely).
- The DDD estimation does not yet match the paper’s own methodological standards for staggered timing and dynamic effects (needs CS/imputation on the gap).
- Mechanism interpretation (“speed increases crash frequency”) is stronger than what can be learned without traffic volume/speed data.

### Publishability after revision
Potentially publishable after major revision if the authors (i) re-estimate DDD using heterogeneity-robust staggered methods, (ii) directly test/defend the road-type-gap assumption with tailored placebos and alternative controls, and (iii) address exposure/substitution concerns or explicitly limit the estimand.

DECISION: MAJOR REVISION